NCT05400525View on ClinicalTrials.gov

Supplementation of YMETA, on Gut Health, Immunity and Metabolism in Pre-diabetic Adult Population

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

June 10, 2023

Study Completion Date

September 20, 2023

Conditions
Pre-diabetes
Interventions
DIETARY_SUPPLEMENT

YMETA

1 sachet containg a total of 3g i.e. 2.5g Galacto-oligosaccharides, 0.5g Bifidobacterium polysaccharides (daily)

OTHER

Placebo control

3g Maltodextrin (i.e. DE 10) daily

Trial Locations (1)

SW15 4JD

Health Sciences Research Centre, Life Sciences Department, University of Roehampton, London

All Listed Sponsors
collaborator

Vemico Ltd.

INDUSTRY

lead

University of Roehampton

OTHER